| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/30/1999 | CN1221407A Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents |
| 06/30/1999 | CN1221405A Substituted amidinobenzene derivatives and medicinal compositions thereof |
| 06/30/1999 | CN1221403A Compounds with anti-inflammatory and immunosuppressive activities |
| 06/30/1999 | CN1221401A Calcilytic compounds |
| 06/30/1999 | CN1221398A 甘露糖醇及其制备 Mannitol and its preparation |
| 06/30/1999 | CN1221349A Cellular vaccines immunotherapeutics and methods for their preparation |
| 06/30/1999 | CN1221347A Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 06/30/1999 | CN1221346A Methods of cancer treatment using NAALADase inhibitors |
| 06/30/1999 | CN1221344A Extractable compounds and method for making and using the same |
| 06/30/1999 | CN1221343A Phosphatidic acid-comprising compositions |
| 06/30/1999 | CN1221342A Oxa acids and related compounds for treating skin conditions |
| 06/30/1999 | CN1221341A Use of benzonaphthalene derivatives to make medicaments for treating disease of central nervous system |
| 06/30/1999 | CN1221340A Use of buckminsterfullerent for treatment of neurotoxic injury |
| 06/30/1999 | CN1221339A Use of inhibitors of cellular Na+/H+ exchanger (NHE) for preparing medicament for normalizing serum lipids |
| 06/30/1999 | CN1221338A Use of H2-antagonists for manufacture of topical composition for treatment of colds |
| 06/30/1999 | CN1221334A Detergent composition for skin |
| 06/30/1999 | CN1220994A Glucoside compound of catechine and preparation method and use thereof |
| 06/30/1999 | CN1220992A Diterpene-kind compound anticancer drug capable of promoting differentiation and depressing proliferation and preparation method and use thereof |
| 06/30/1999 | CN1220875A Ontagonism of glycine and its composite (containing mixture) against endotoxin and clinical application |
| 06/30/1999 | CN1220873A Method for manufacture troche for eliminating gastrointestinal vesicle and its application |
| 06/30/1999 | CN1043893C Pharmaceuticals |
| 06/30/1999 | CN1043889C Process for the preparation of substituted benzenes and benzene sulfonic acid and derivatives thereof |
| 06/30/1999 | CN1043887C Chemopreventive compound and preparation method and use thereof |
| 06/30/1999 | CN1043884C New substituted azacylobutanone, preparation method and medicinal use thereof |
| 06/30/1999 | CN1043883C Vitamin D analogues, medicinal composition containing the same and medical use thereof |
| 06/30/1999 | CA2256002A1 7-bromo- and 7,7-dibromo-cepham and cephem derivatives |
| 06/29/1999 | US5917670 In a hard disk drive |
| 06/29/1999 | US5917088 Salicyclic acid derivatives, process of preparation and uses thereof |
| 06/29/1999 | US5917084 Antifungal agents |
| 06/29/1999 | US5917082 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 06/29/1999 | US5917070 Ethylene oxide-propylene oxide copolymer |
| 06/29/1999 | US5917062 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs |
| 06/29/1999 | US5917056 10-deacetyl-14β-hydroxybaccactine III derivatives, a process for the preparation thereof and formulations containing them |
| 06/29/1999 | US5917055 Captopril |
| 06/29/1999 | US5917053 Inhibiting gaba release from neurons |
| 06/29/1999 | US5917052 Hypoglycemic agent from cryptolepis |
| 06/29/1999 | US5917048 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 06/29/1999 | US5917047 Heterocyclic compounds |
| 06/29/1999 | US5917034 Antithrombotic n-amidinopiperidine and benzamidine derivatives |
| 06/29/1999 | US5917007 Alkylated and crosslinked polyallylamine, polyvinylamine, polyethylenimine or diethylenetriamine-epichlorohydrin copolymer |
| 06/29/1999 | US5916925 Orally administering an effective amount of idebenone to a patient with senile dementia of alzheimer's type or alzheimer's disease |
| 06/29/1999 | US5916924 Remedies for liver diseases |
| 06/29/1999 | US5916923 Venlafaxine for the treatment of generalized anxiety disorder |
| 06/29/1999 | US5916922 For inhibiting human non-pancreatic secretory phospholipase a2 |
| 06/29/1999 | US5916921 Therapeutic agents for liver regeneration |
| 06/29/1999 | US5916919 Retrovirus protease inhibitors |
| 06/29/1999 | US5916918 Bedsore |
| 06/29/1999 | US5916916 Useful as selective estrogen receptor modulators. |
| 06/29/1999 | US5916913 Antiscarring agent |
| 06/29/1999 | US5916912 Orally administering to the host an effective dosage of a carnitine, such as acetyl-l-carnitine, and a mitochondrially active antioxidant, such as lipoic acid; restores mitochondiral functions; mitigation of indicia of aging |
| 06/29/1999 | US5916911 Antitumor |
| 06/29/1999 | US5916910 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore |
| 06/29/1999 | US5916908 Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases |
| 06/29/1999 | US5916907 Administering an effective amount of n-(3,4-dimethyl-5-isoxazolyl)-4'-(2-oxazolyl)(1,1-biphenyl)-2-sufonamide or a salt as an endothelin antagonist |
| 06/29/1999 | US5916906 Compositions comprising nicotinylalanine and an inhibitor of glycine conjugation or vitamin B6 |
| 06/29/1999 | US5916904 Antiulcer |
| 06/29/1999 | US5916903 Method for reducing the effects of antineoplastic disease treatment |
| 06/29/1999 | US5916901 Heterocyclic compounds |
| 06/29/1999 | US5916898 Phenanthroline derivatives |
| 06/29/1999 | US5916897 Process for the preparation of 9-amino camptothecin |
| 06/29/1999 | US5916896 Antitumor agents; leukemia therapy |
| 06/29/1999 | US5916894 Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines |
| 06/29/1999 | US5916893 Treatment of a latent infection of herpes virus |
| 06/29/1999 | US5916890 N-benzoyl-1-piperazinylcarbostyril derivatives |
| 06/29/1999 | US5916889 1,4-disubstituted piperazines |
| 06/29/1999 | US5916888 Imidazo 1,5A!pyridine derived serine protease inhibitors |
| 06/29/1999 | US5916887 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 06/29/1999 | US5916885 Treatment of psoriasis, dermatitis |
| 06/29/1999 | US5916884 Cytotoxic therapeutic compound; antitumor agent |
| 06/29/1999 | US5916882 Povidone iodine (PVP-I) alcohol gel antimicrobial pre-operative skin preparation |
| 06/29/1999 | US5916880 Using a sulfated saccharide |
| 06/29/1999 | US5916878 Dipeptide of either gamma-glutamyl-l-tryptophan or beta-aspartyl-l-tryptophan; administering to the patients to reduce the risks infections from microorganism |
| 06/29/1999 | US5916870 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 06/29/1999 | US5916808 Hybridizing to pre-messenger rna at splice element of native intron, thus creating duplex and permitting splicing; oligonucleotide does not activate rnaase h and blocks mutant splice elements; treatment of beta-thalassemia |
| 06/29/1999 | US5916792 Jak3 plays a role in the growth factor modulated differentiation/proliferation of the stem/progenitor cells. |
| 06/29/1999 | US5916769 Polynucleotides encoding extra cellular/epidermal growth factor HCABA58X polypepides |
| 06/29/1999 | US5916618 Pesticide for medicated feedstuff, dietary concentrate or supplement |
| 06/29/1999 | US5916598 First and second phases are combined to form an emulsion in which the first phase is discontinuous and the second phase is continuous. the phases are immersed in a quench liquid. |
| 06/29/1999 | US5916596 Water insoluble drugs and drug delivery |
| 06/29/1999 | US5916595 HMG co-reductase inhibitor |
| 06/29/1999 | US5916593 Process of making dosage units by wet granulation |
| 06/29/1999 | US5916590 Soft gelatin pharmaceutical dosage form |
| 06/29/1999 | US5916587 Transdermal delivery matrix for piroxicam |
| 06/29/1999 | US5916583 Precipitation of one or more active compounds in situ |
| 06/29/1999 | US5916579 Process for combating adiposity and compositions which may be used for this purpose |
| 06/29/1999 | US5916576 Orange extract obtained from orange peel, orange flowers or orange leaves and contains less than 1% ascorbic acid; anti-radical activity towards superoxide radical; antiaging agent; cosmetics |
| 06/29/1999 | US5916574 Method of treating natural poison skin conditions |
| 06/29/1999 | US5916566 Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds |
| 06/29/1999 | US5916565 Antiarthritic agent consists of a palatability agent, cayenne, ginger, yucca roots, devil's claw, black cohosh, nettle leaf, tumeric, alfalfa, celery seeds, glucosamine hydrochlorie and mucopolysaccharide |
| 06/29/1999 | US5916564 Tripterygium wilfordii Hook F extracts and components thereof for immunosuppression |
| 06/29/1999 | US5916556 Human MRNA editing enzyme |
| 06/29/1999 | US5916550 C2-7 aliphatic amino acid is added to an aqueous suspension of loteprednol etabonate for topical ophthalmic use, the suspension does not undergo ph depression even on prolonged storage, with the result that no irritable response is |
| 06/29/1999 | US5916545 Topical antifungal agent consists of tioconazole, water, alcohol and water soluble gel forming agent selected from a resin derived from cellulose, glucose or sucrose and a plasticizer; useful for treating onychomycosis |
| 06/29/1999 | US5916540 Aerosol formulations containing P134A and/or P227 and particulate medicament |
| 06/29/1999 | US5916539 Superparamagnetic particles, process for producing the same and their use |
| 06/29/1999 | US5916371 Crystalline powdery saccsharide, its preparation and uses |
| 06/29/1999 | CA2255202A1 Use of flavin adenine dinucleotide in the preparation of ophthalmic formulations for the treatment of dry eye |
| 06/29/1999 | CA2156063C Sucrose ester c-20 to c-28 alcohol formulations |
| 06/29/1999 | CA2146475C Process for the preparation of azithromycin dihydrochloride |
| 06/29/1999 | CA2134211C Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient |